DICLOFENAC POTASSIUM
| Brand name | CAMBIA |
|---|---|
| Active ingredient | DICLOFENAC POTASSIUM |
| Strength | 50MG |
| Dosage form | FOR SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8097651 | June 2026 | substance, product |
| 7759394 | June 2026 | substance, product |
| 8927604 | June 2026 | use U-436 |
| 9827197 | June 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.